Royal Bank Of Canada Has Lowered Expectations for Amentum (NYSE:AMTM) Stock Price

Amentum (NYSE:AMTM) had its price objective decreased by analysts at Royal Bank Of Canada from $28.00 to $26.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 17.66% from the company’s current price.

Several other equities analysts have also recently commented on the stock. Weiss Ratings cut shares of Amentum from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, June 23rd. BTIG Research lowered their target price on shares of Amentum from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Wednesday. Bank of America cut their price target on shares of Amentum from $35.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, July 20th. BNP Paribas Exane initiated coverage on shares of Amentum in a research report on Tuesday, May 26th. They set an “underperform” rating and a $22.00 price target for the company. Finally, Zacks Research upgraded Amentum from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Amentum presently has a consensus rating of “Hold” and an average price target of $29.83.

Amentum Stock Performance

Shares of NYSE AMTM traded down $0.33 during mid-day trading on Wednesday, reaching $22.10. 167,764 shares of the company’s stock were exchanged, compared to its average volume of 2,035,155. The firm has a market capitalization of $5.40 billion, a price-to-earnings ratio of 26.61, a price-to-earnings-growth ratio of 0.71 and a beta of 0.30. Amentum has a 52 week low of $19.80 and a 52 week high of $38.11. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.48 and a quick ratio of 1.48. The firm has a 50-day moving average price of $21.86 and a two-hundred day moving average price of $26.00.

Amentum (NYSE:AMTM) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.06. The company had revenue of $3.49 billion during the quarter, compared to analyst estimates of $3.57 billion. Amentum had a return on equity of 12.27% and a net margin of 1.44%.The firm’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.56 EPS. Amentum has set its FY 2026 guidance at 2.400-2.500 EPS. Analysts predict that Amentum will post 2.36 EPS for the current year.

Institutional Trading of Amentum

A number of hedge funds have recently made changes to their positions in AMTM. IFM Investors Pty Ltd purchased a new position in Amentum in the 1st quarter worth about $411,000. Cetera Investment Advisers purchased a new position in Amentum during the second quarter valued at approximately $335,000. JPMorgan Chase & Co. boosted its position in shares of Amentum by 4.1% in the second quarter. JPMorgan Chase & Co. now owns 91,322 shares of the company’s stock worth $2,156,000 after purchasing an additional 3,608 shares during the period. M&T Bank Corp purchased a new stake in shares of Amentum in the second quarter worth $241,000. Finally, Gabelli Funds LLC purchased a new stake in shares of Amentum in the second quarter worth $592,000. 39.93% of the stock is owned by institutional investors.

Trending Headlines about Amentum

Here are the key news stories impacting Amentum this week:

• Positive Sentiment: Amentum reported third-quarter fiscal 2026 adjusted earnings of $0.67 per share, exceeding analyst estimates of approximately $0.61-$0.63 and rising from $0.56 a year earlier. Amentum Reports Third Quarter Fiscal Year 2026 Results
• Positive Sentiment: The company is teaming up on efforts intended to accelerate nuclear reactor approvals, potentially benefiting its nuclear engineering and advanced technology business if regulatory timelines improve. Why Is Amentum Holdings Teaming Up To Speed Nuclear Reactor Approval?
• Positive Sentiment: BTIG Research maintained a “buy” rating, indicating continued confidence in Amentum’s longer-term prospects and assigning a $30 price target, which remains materially above the stock’s recent trading level. BTIG Lowers Amentum Price Target
• Neutral Sentiment: Management reaffirmed fiscal 2026 EPS guidance of $2.40-$2.50, broadly consistent with analyst expectations, but set revenue guidance at $13.8 billion-$14.0 billion versus consensus of approximately $14.2 billion.
• Negative Sentiment: Third-quarter revenue totaled $3.49 billion, below the $3.57 billion consensus estimate, and declined 2% year over year. The revenue miss and lower sales outlook appear to be the main catalysts behind the stock’s weakness following the earnings release. Amentum Misses Revenue Estimates
• Negative Sentiment: BTIG reduced its price target from $35 to $30, signaling more cautious expectations even though the firm retained its bullish rating.

About Amentum

Amentum is a government services provider specializing in mission-critical solutions for defense, federal civilian and commercial customers around the globe. The company delivers integrated services that span the full lifecycle of complex programs and facilities, including engineering, program and project management, logistics, operations, maintenance and environmental remediation.

Core offerings include infrastructure support, energy and facilities management, environmental solutions and nuclear services.